Icanic Brands Company, Inc. Posts Record Second Quarter 2022 Financial Results
Icanic Brands Company (CSE: ICAN, OTCQB: ICNAF) reports strong financial results for the three and six months ended June 30, 2022. Net sales reached $8,121,247 for Q2 and $15,490,633 year-to-date, marking increases of 26.5% and 84.9% year-over-year, respectively. The company achieved a gross profit of $2,684,101 for Q2, with a gross margin of 33.05%. Adjusted EBITDA was ($31,801) for Q2 and $1,589,719 year-to-date. CEO Micah Anderson highlighted the positive impacts of the LEEF acquisition and ongoing strategic partnerships aimed at enhancing brand presence in California.
- Q2 2022 net sales of $8,121,247, up 26.5% year-over-year.
- Year-to-date revenue of $15,490,633, up 84.9% year-over-year.
- Gross profit of $2,684,101 for Q2, with a gross margin of 33.05%.
- Ongoing integration with LEEF Holdings expected to drive further synergies.
- Adjusted EBITDA of ($31,801) for Q2 due to one-time transaction costs.
Insights
Analyzing...
VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Icanic Brands Company Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator of premium cannabis brands in California, is pleased to report its financial results for the three and six months ended June 30th, 2022. All currency references used herein are in United States dollars unless otherwise noted.
Micah Anderson, CEO of Icanic, said, “The past few months have been the beginning of a transformational period for the Company. Immediately upon closing of the acquisition of LEEF Holdings, Inc. (“LEEF”) we began turning the contemplated synergies into concrete and measurable results. Despite a challenging macro environment, we have been able to drive revenue growth and management costs that are propelling us towards profitability. We are seeing month over month evidence of the substantial growth prospects of our business.”
Corporate Highlights:
- Net sales of
$8,121,247 for the three months ended and$15,490,633 for the six months ended June 30th, 2022, representing an increase in Icanic Brands year over year revenue of26.5% and84.9% respectively. - Gross Profit of
$2,684,101 for the three months ended and$5,722,194 for the six months ended June 30th, 2022. - Gross Margin of
33.05% for the three months ended and36.94% for the six months ended June 30th, 2022, representing an increase in Icanic Brands year over year gross margin of13.8% and16.4% respectively. - Adjusted EBITDA of (
$31,801) for the three months ended and$1,589,719 for the six months ended June 30, 2022.
Management Commentary:
“The results are in-line with our expectations as we experienced a significant increase in revenue due to the acquisition of LEEF, but also incurred several one-time transaction related costs. The quarter’s strong gross margins are a strong indication that we are on the right track with our consumer-packaged goods strategy, which includes distribution of brands including Ganja Gold, HEADY and Real Deal Resin. I expect we will continue to realize additional synergies over the coming months.”
“We’re continuing our work with strategic partners to increase our brand presence throughout the state. We’re also continuing our conversations to make the Company fully integrated, including finalizing the previously announced acquisition of DNA Organics, Inc. (“LIFTED”), a premium California cultivator and manufacturer. We’re poised to increase efficiencies and deliver the highest quality cannabis products at the lowest cost of manufacturing. Additionally, we have a robust pipeline of potential acquisitions that are currently being reviewed.”
Q2 2022 Financial Results Discussion
Total revenue for the three months ended June 30th, 2022 was
Consumer packaged goods (“CPG”) revenue continues to increase as a percentage of overall sales as the Company works to increase the distribution of its brands, including Ganja Gold, HEADY and Real Deal Resin.
Gross profit was
Adjusted EBITDA was (
Financial results and analyses will be available on the Company's investor relations website (https://www.icaninc.com/investors) and SEDAR (www.sedar.com).
About Icanic Brands Company Inc.
Icanic Brands Company Inc. is a leading cannabis branded products manufacturer based in California, the largest and most competitive cannabis markets in the world. The company’s mission is to make cannabis safe and approachable - that starts with manufacturing high-quality products delivering consistent experiences.
For more information, please visit the company’s website at: www.icaninc.com.
ICANIC BRANDS COMPANY INC.
Per: “Micah Anderson”
Chief Executive Officer
For further information about Icanic Brands, please contact the Company at:
Email: ir@icaninc.com
Phone: (778)999-4226
The CSE does not accept responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Non-IFRS Measures
This press release includes reference to “EBITDA” which is a non-International Financial Reporting Standards (“IFRS”) financial measures. Non-IFRS measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS, and are therefore unlikely to be comparable to similar measures presented by other companies. The Company defines EBITDA as earnings before interest, tax, depreciation and amortization and removal of non-reoccurring expenses. EBITDA has no direct, comparable IFRS financial measure. The Company has used or included EBITDA solely to provide investors with added insight into the Company’s potential financial performance. Readers are cautioned that such non-IFRS measures may not be appropriate for any other purpose. Non-IFRS measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.
